chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: DTAP, HEP
Symptoms: Product storage error
Clinical narrative: Administration after temperature excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 8-year-old male patient who received HBV (Engerix B) (batch number 4VN3H) for prophylaxis.   Co-suspect products included DTPa (Infanrix) (batch number Z53J4) for prophylaxis.   On 29-AUG-2024, the patient received Engerix B and Infanrix. On an unknown date, an unknown time after receiving Engerix B and Infanrix, the patient experienced incorrect storage of drug (Verbatim: Administration after temperature excursion). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 08-NOV-2024 and 11-NOV-2024 Medical assistant called us to request stability data for Engerix-B and Infanrix, this due to a below temperature excursion, they provided it and then she asked what if the vaccines were given to the patients, which led to incorrect storage of vaccine. The patient received Engerix-B and Infanrix on 29Aug2024 (both vaccines on same date). The reporter reported the following excursions for this vaccine: For May: 1) 15 May 2024: a temperature of 32.2 degree F, for 2 hours and 30 min 2) 16 May 2024: a temperature of 30.6 degree F, for 7 hours and 2 minutes 3) 21 May 2024: a temperature of 34.7 degree F, for 32 minutes 4) 31May 2024: a temperature of 35.2 degree F, for 18 minutes For June 1) 13 Jun 2024: a temperature of 32.9 degree F, for 58 minutes For July 1) 26 Jul 2024: a temperature of 32.2 degree F, for 43 minutes For Sep 1) 04 Sep2024: a temperature of 34.3 degree F, for 2 hours and 14 minutes No other prior excursions. The reporter consented to follow up.  The Vaccine Administration Facility is the same as Primary Reporter. This was 1 of 5 linked cases, reported by the same reporter.; Sender's Comments:  US-GSK-US2024139692:Same reporter US-GSK-US2024139716:Same reporter US-GSK-US2024139715:Same reporter US-GSK-US2024139710:Same reporter
Sex: M
Vaccine: HEP
Symptoms: Product storage error
Clinical narrative: vaccines exposed to the excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 1-year-old male patient who received HBV (Engerix B) (batch number 4VN3H) for prophylaxis.   On 28-AUG-2024, the patient received Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced incorrect storage of drug (Verbatim: vaccines exposed to the excursion). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 08-NOV-2024 and 11-NOV-2024 Medical assistant called us to request stability data for Engerix-B and Infanrix, this due to a below temperature excursion, we provided it and then she asked what if the vaccines were given to the patients, which led to incorrect storage of drug. The reporter wanted to know that this patient received only Engerix B, one of the vaccines exposed to the excursion. The reporter reported the following excursions for this vaccine: For May:1) 15 May 2024: a temperature of 32.2 degree F, for 2 hours and 30 min 2) 16 May 2024: a temperature of 30.6 degree F, for 7 hours and 2 minutes 3) 21 May 2024: a temperature of 34.7 degree F, for 32 minutes 4) 31May 2024: a temperature of 35.2 degree F, for 18 minutes For June,1) 13 Jun 2024: a temperature of 32.9 degree F, for 58 minutes For July, 1) 26 Jul 2024: a temperature of 32.2 degree F, for 43 minutes For September, 1) 04 Sep2024: a temp. of 34.3 degree F, for 2 hours and 14 minutes The Vaccine Administration Facility is the same as Primary Reporter. No other prior excursions. The reporter consented to follow up. This was 1 of 5 linked cases, reported by the same reporter.; Sender's Comments:  US-GSK-US2024139708:Same reporter US-GSK-US2024139715:Same reporter US-GSK-US2024139716:Same reporter US-GSK-US2024139692:Same reporter
Sex: F
Vaccine: HEP
Symptoms: Product storage error
Clinical narrative: vaccines exposed to the excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 9-year-old female patient who received HBV (Engerix B) (batch number 4VN3H) for prophylaxis.   On 26-OCT-2024, the patient received Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced incorrect storage of drug (Verbatim: vaccines exposed to the excursion). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 08-NOV-2024 and 11-NOV-2024 Medical assistant called us to request stability data for Engerix-B and Infanrix, this due to a below temperature excursion, we provided it and then she asked that what if the vaccines were given to the patients, which led to incorrect storage of vaccine. The reporter knew that this patient received only Engerix-B, one of the vaccines exposed to the excursion. The reporter reported the following excursions for this vaccine: For May: 1) 15 May 2024: a temp. of 32.2 degree F, for 2 hours and 30 minutes. 2) 16 May 2024: a temperature of 30.6 degree F, for 7 hours and 2 minutes. 3) 21 May 2024: a temperature of 34.7 degree F, for 32 minutes. 4) 31May 2024: a temperature of 35.2 degree F, for 18 minutes. For June: 1) 13 Jun 2024: a temperature of 32.9 degree F, for 58 minutes. For July: 1) 26 Jul 2024: a temperature of 32.2 degree F, for 43 minutes. For September:1) 04 Sep2024: a temperature of 34.3 degree F, for 2 hours and 14 minutes. No other prior excursions were reported. The reporter consented to follow up. The Vaccine Administration Facility is the same as Primary Reporter. This was 1 of 5 linked cases, reported by the same reporter.; Sender's Comments:  US-GSK-US2024139692:Same reporter US-GSK-US2024139708:Same reporter US-GSK-US2024139710:Same reporter US-GSK-US2024139715:Same reporter
Sex: F
Vaccine: DTAP
Symptoms: Product storage error
Clinical narrative: Patient received only Infanrix on 28Aug2024, one of the vaccines exposed to the excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 7-year-old female patient who received DTPa (Infanrix) (batch number Z53J4) for prophylaxis.   On 28-AUG-2024, the patient received Infanrix. On an unknown date, an unknown time after receiving Infanrix, the patient experienced incorrect storage of drug (Verbatim: Patient received only Infanrix on 28Aug2024, one of the vaccines exposed to the excursion). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 08-NOV-2024 and 11-NOV-2024 Medical assistant called us to request stability data for Engerix-B and Infanrix, this due to a below temperature excursion, we provided it and then she asked what if the vaccines were given to the patients. The reporter wanted to know that this patient received only Infanrix, one of the vaccines exposed to the excursion. The reporter reported the following excursions for this vaccine: For May:1) 15 May 2024: a temperature of 32.2 degree F, for 2 hours and 30 min 2) 16 May 2024: a temperature of 30.6 degree F, for 7 hours and 2 minutes 3) 21 May 2024: a temperature of 34.7 degree F, for 32 minutes 4) 31May 2024: a temperature of 35.2 degree F, for 18 minutes For June,1) 13 Jun 2024: a temperature of 32.9 degree F, for 58 minutes For July, 1) 26 Jul 2024: a temperature of 32.2 degree F, for 43 minutes For September, 1) 04 Sep2024: a temp. of 34.3 degree F, for 2 hours and 14 minutes The Vaccine Administration Facility is the same as Primary Reporter. No other prior excursions. The reporter consented to follow up. This was 1 of 5 linked cases, reported by the same reporter.; Sender's Comments:  US-GSK-US2024139708:Same reporter US-GSK-US2024139692:Same reporter US-GSK-US2024139716:Same reporter US-GSK-US2024139710:Same reporter
Sex: U
Vaccine: COVID19
Symptoms: Paralysis
Clinical narrative: I had a strong reaction/paralyzed/I couldn't move at all for a day; This spontaneous case was reported by an other health care professional and describes the occurrence of PARALYSIS (I had a strong reaction/paralyzed/I couldn't move at all for a day) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ASKU) for COVID-19 prophylaxis.     Concurrent medical conditions included Multiple sclerosis relapse.    In May 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARALYSIS (I had a strong reaction/paralyzed/I couldn't move at all for a day) (seriousness criterion medically significant). At the time of the report, PARALYSIS (I had a strong reaction/paralyzed/I couldn't move at all for a day) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication were reported.  It was reported that when I got my COVID vaccine, the Moderna. I had a strong reaction" further described as when I took my second dose I was paralyzed for a day, I could not move at all.   Most recent FOLLOW-UP information incorporated above includes: On 25-Nov-2024: Live follow-up received which contains non-significant information, reference number added.; Reporter's Comments: Concurrent medical condition of multiple sclerosis relapse remains a confounder for event of paralysis. The benefit-risk relationship of the product is not affected by this report.
Sex: U
Vaccine: UNK
Symptoms: Arthralgia, Induration, Lymphadenopathy, Neck pain, Pain
Clinical narrative: swollen lymph nodes; intense pain that radiates from the elbow into their neck; large, localized reactions with large induration and redness; large, localized reactions with large induration and redness; Initial information received on 27-Nov-2024 regarding an unsolicited valid non-serious case received from a other health professional.  The case is linked to US-SA-2024SA359516 and US-SA-2024SA353552.  This case involves an unknown age and unknown gender patient who experienced swollen lymph nodes, intense pain that radiates from the elbow into their neck, large, localized reactions with large induration after receiving Influenza Trivalent Recombinant Vaccine [Flublok TIV].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date in 2024, the patient received a dose of 0.5 ml 1x suspect Influenza Trivalent Recombinant Vaccine (Solution for injection ) strength, expiry date, lot number not reported via unknown route in unknown administration site for Prophylactic vaccination (Immunization). There will be no information on batch number and expiration date corresponding to the one at time of event occurrence.   On an unknown date in 2024 the patient developed swollen lymph nodes (lymphadenopathy), intense pain that radiates from the elbow into their neck (pain) ,large, localized reactions with large induration and redness (vaccination site induration) and (vaccination site erythema) (unknown latency) following the administration of Influenza Trivalent Recombinant Vaccine.  Reportedly "ave had 3patients that have had more extreme reactions to this seasons Flublok.  2 people wound up with swollen lymph nodes and one had moderate swelling in his armpit.Rep said that he asked if the patients were okay, and she responded that they are Okay."  Action taken was not applicable for all the events.  It was not reported if the patient received a corrective treatment for the events (intense pain that radiates from the elbow into their neck, large, localized reactions with large induration and redness, swollen lymph nodes, large, localized reactions with large induration and redness).  At time of reporting, the outcome was Recovering / Resolving for all the events.; Sender's Comments:  US-SA-2024SA359516: US-SA-2024SA353552:
Age: 56.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Pulmonary embolism
Clinical narrative: Hospitalized bilateral pulmonary embolisms now on oxygen
Age: 50.0
Sex: M
Vaccine: FLU3
Symptoms: Extra dose administered
Clinical narrative: Flu vax - 11/8/2024 & 12/5/2024
Age: 63.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Reported Symptoms: 10022098: INJECTION SITE REDNESS; Narrative: Other Relevant HX: Other: raised circular reddened area approx 1.5 - 2 inches above right elbow on right lateral arm. States was given pneumonia vaccine at that site on 10/21/2024. Reports has increased in size over the past 2 days. It is approximately 6cm diameter and warm t
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, C-reactive protein increased, Catheterisation cardiac abnormal, Chest pain, Coronary artery disease
Clinical narrative: Reported Symptoms: 10003239: ARTHRALGIA; 10019211: HEADACHE; 10034484: PERICARDITIS; Narrative: 70 year old man with paraplegia due to SCI (2007), neurogenic bowel/bladder, dm2, htn, myeloproliferative disease, h/o uti's who was transferred to outside hospital on 10/14/24 due to chest pain that started the evening before which was sharp in nature and worse with breathing. Cardiology took patient to cath lab with concern of inferior STEMI due to EKG but showed mild-moderate CAD and STEMI ruled out. Troponin's were never elevated. He was diagnosed with acute pericarditis (CRP - 26) and ST elevations in multiple leads TTE showed physiologic pericardial effusion, normal LV function EF-55-60%. He was started on colchicine and high dose ibuprofen for acute pericarditis. Patient received the COVID-19 vaccine (Comirnaty) on 10/8/24 at 9:49am. Patient had previously received COVID-19 vaccines in 2021 and 2022 with no known pericarditis following administration. Patient received flu shot (Fluzone HD) on 9/19/24 at 10:47 am. Other Relevant HX: Other: pericarditis
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram, Ejection fraction normal, Electrocardiogram ST segment elevation, Headache, Painful respiration
Clinical narrative: Reported Symptoms: 10003239: ARTHRALGIA; 10019211: HEADACHE; 10034484: PERICARDITIS; Narrative: 70 year old man with paraplegia due to SCI (2007), neurogenic bowel/bladder, dm2, htn, myeloproliferative disease, h/o uti's who was transferred to outside hospital on 10/14/24 due to chest pain that started the evening before which was sharp in nature and worse with breathing. Cardiology took patient to cath lab with concern of inferior STEMI due to EKG but showed mild-moderate CAD and STEMI ruled out. Troponin's were never elevated. He was diagnosed with acute pericarditis (CRP - 26) and ST elevations in multiple leads TTE showed physiologic pericardial effusion, normal LV function EF-55-60%. He was started on colchicine and high dose ibuprofen for acute pericarditis. Patient received the COVID-19 vaccine (Comirnaty) on 10/8/24 at 9:49am. Patient had previously received COVID-19 vaccines in 2021 and 2022 with no known pericarditis following administration. Patient received flu shot (Fluzone HD) on 9/19/24 at 10:47 am. Other Relevant HX: Other: pericarditis
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pericardial effusion, Pericarditis, Troponin normal
Clinical narrative: Reported Symptoms: 10003239: ARTHRALGIA; 10019211: HEADACHE; 10034484: PERICARDITIS; Narrative: 70 year old man with paraplegia due to SCI (2007), neurogenic bowel/bladder, dm2, htn, myeloproliferative disease, h/o uti's who was transferred to outside hospital on 10/14/24 due to chest pain that started the evening before which was sharp in nature and worse with breathing. Cardiology took patient to cath lab with concern of inferior STEMI due to EKG but showed mild-moderate CAD and STEMI ruled out. Troponin's were never elevated. He was diagnosed with acute pericarditis (CRP - 26) and ST elevations in multiple leads TTE showed physiologic pericardial effusion, normal LV function EF-55-60%. He was started on colchicine and high dose ibuprofen for acute pericarditis. Patient received the COVID-19 vaccine (Comirnaty) on 10/8/24 at 9:49am. Patient had previously received COVID-19 vaccines in 2021 and 2022 with no known pericarditis following administration. Patient received flu shot (Fluzone HD) on 9/19/24 at 10:47 am. Other Relevant HX: Other: pericarditis
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Reported Symptoms: 10013573: DIZZINESS; Narrative: Other Relevant HX: Other.
Age: 78.0
Sex: M
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Reported Symptoms: 10067482: NO ADVERSE EVENT; Narrative: The patient has it documented that he received the RSV vaccine on 11/20/2023 and is not indicated to receive another dose. Investigation: Order entered at 1134. Discontinued at 1154 by pharmacist. Order was administered at 1144 (prior to any verification by pharmacy - because it was never verified, it was d/c). 1. Best practice is to ensure order is verified PRIOR to admission. In this case the pharmacist did catch thtat this was not indicated and got the order D/C but it was already given. 2. Immunizations tab should always be checked PRIOR to giving/ordering vaccines. This needs to be sent to RN and provider to inform that RSV is currently a "one and done" vaccine, NOT seasonal. Will also submit to agency/VAERS. Other Relevant HX: Other None
Sex: M
Vaccine: FLUX
Symptoms: Rash
Clinical narrative: Reported Symptoms: 10037844: RASH; Narrative: A 58yo male with MH of Homelessness, Motor Vehicle Accident, Generalized Muscle weakness, Obesity, HTN, DM, HLD, Vitamine D deficiency, Thiamine Deficiency, OSA, GERD, Ed, Low Back Pain, Anxiety and Bilateral OA of Knees. On September 2, 2024 Medical Cr physician reported the patient had a historical ADR of influenza virus vaccine induced rash. NO other information was provided by the reported including the vaccine mfg, lot number, exp date, where and by who it was administered. Patient's immunization record showed he had received Influenza vaccine (2014, 2017, 2018) and Flu vaccines (2013, 2020). Other Relevant HX: Other; RASH
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Malaise, Pruritus, Rash
Clinical narrative: Reported Symptoms: 10037087: PRURITUS; 10037844: RASH; Narrative: Pt declined to receive second dose of zoster vaccine 11/16/23 stating #1 vaccine made him sick. Provider flagged Pt's chart with "severe itching" from vaccine. No other documentation found in chart. Other Relevant HX: n/a Other: RASH
Age: 71.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: Reported Symptoms: 10008531: CHILLS; 10016558: FEVER; 10028411: MYALGIA; 10028813: NAUSEA; 10047700: VOMITING; Narrative: Other Relevant HX: Other: FEVER: NAUSEA: CHILL
Age: 61.0
Sex: M
Vaccine: TDAP, VARZOS
Symptoms: Rash
Clinical narrative: Reported Symptoms: Narrative: Other Relevant HX: Other: RASH
Sex: M
Vaccine: RSV
Symptoms: Extra dose administered
Clinical narrative: Reported Symptoms: 100067482: NO ADVERSE EVENT; Narrative: Patient received RSV vaccine in 2023 and it was ordered again in 2024 and given. Dose was given prior to order being verified by pharmacy. At time of pharmacy review, the order was discontinued but patient had already received it. Other Relevant HX: Other: none
Age: 81.0
Sex: M
Vaccine: FLU3, RSV
Symptoms: Swelling face
Clinical narrative: Reported Symptoms: 10014222: EDEMA FACE; Narrative: Patient reported to RN that the day after receiving both vaccines his face felt swollen and puffy. He had no difficulty breathing and it was not localized to lips/tongue. The next day (10/26/24) all issues resolved. Other Relevant HX: Other: swelling of face
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Erythema, Rash
Clinical narrative: Reported Symptoms: 10005216: BLISTERS; 10015150: ERYTHEMA; 10037844: RASH; Narrative: Per Teledermatology note: "There is a rectangle of erythema with blisters. This favors allergic contact dermatitis to an adhesive." Patient RX'd topical steroid BID x 2 weeks with resolution Other Relevant HX: Other erythema with blisters
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Reported Symptoms: 10037844: RASH; Narrative: Other Relevant HX:
Sex: M
Vaccine: FLUX
Symptoms: Craniocerebral injury, Exposure to toxic agent, Migraine, Post-acute COVID-19 syndrome, Throat tightness
Clinical narrative: Reported Symptoms: 10043528: THROAT TIGHTNESS; Narrative: A 46yo male iwth PMH of TBI, Chronic PTSD, Migraine, Tinnitus and Exposure to Potentially Hazardous substances. Per attending physician's note on August 21, 2024, the patient presented to the Primary Care clinic to establish care. The MD under Vaccine allergy documented the patient had Flu shot induced "throat swelling", last got in 1999" No other information was provided. Unable to find on patient's immunization history. Other Relevant HX: Other: SWELLING OF THROAT (in 1999)
Sex: M
Vaccine: FLUX
Symptoms: Tinnitus
Clinical narrative: Reported Symptoms: 10043528: THROAT TIGHTNESS; Narrative: A 46yo male iwth PMH of TBI, Chronic PTSD, Migraine, Tinnitus and Exposure to Potentially Hazardous substances. Per attending physician's note on August 21, 2024, the patient presented to the Primary Care clinic to establish care. The MD under Vaccine allergy documented the patient had Flu shot induced "throat swelling", last got in 1999" No other information was provided. Unable to find on patient's immunization history. Other Relevant HX: Other: SWELLING OF THROAT (in 1999)
Sex: M
Vaccine: FLUX
Symptoms: Syringe issue, Underdose
Clinical narrative: Reported Symptoms: 10069327: PRODUCT QUALITY ISSUE; 10069892: SYRINGE LEAK; Narrative: While administering influenza vaccine to patient (__) with needle inserted into the skin liquid from syringe leaked out underneath syringe and dripped down patients arm resulting in patient not getting any of the vaccine injected. Patient was not injured from this event. Needle was not over tightened, no cracks noted in syringe tip/needle. Other Relevant HX: Other: syringe leaked
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: Reported Symptoms: 10028322: MUSCLE PAIN; Narrative: Patient developed muscle aches and fatigue after receiving the vaccine. He was not treated with any medications. Other Relevant HX: Other: MUSCLE PAIN
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Malaise, Pyrexia
Clinical narrative: Reported Symptoms: 10016558: FEVER; 10022437: INSOMNIA; 10025481: MALAISE; Narrative: Patient was given vaccine and experienced fever, malaise, and insomnia. Other Relevant HX: Other: FEVER; INSOMNIA; MALAISE
Age: 77.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site pain, Skin swelling
Clinical narrative: Reported Symptoms: 10022086: INJECTION SITE PAIN; 10053262: SKIN SWELLING; Narrative: Other Relevant HX: Other: skin swelling and pain at injection site that has lasted 3 months
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Syringe issue
Clinical narrative: Reported Symptoms: 10069327: PRODUCT QUALITY ISSUE; Narrative: Nurse reported - the flu vaccine leaked out from the syringe while injecting into patient. Influenza, Standard-Dose, Trivalent, Preservative Free (Fluarix-Syringe) lot# : NG5FM expiration date: 6/30/25 Other Relevant HX: Other: leaking vaccine
Age: 58.0
Sex: M
Vaccine: COVID19, FLU3
Symptoms: Angioedema
Clinical narrative: Reported Symptoms: 10002424: ANGIOEDEMA; Narrative: Other Relevant HX: Other
Age: 79.0
Sex: M
Vaccine: FLUX
Symptoms: Extra dose administered
Clinical narrative: Reported Symptoms: 10064366: EXTRA DOSE ADMINISTERED; Narrative: Patient came to flu clinic to receive a flu shot. Patient registered and was asked if he had received a flu shot this year. He was then asked again by two nursing staff if vaccine was received this year to which the patient insisted he had not received yet this year. Flu vaccine was given by specialty nurse. When charting was being completed it was discovered that vaccine was previously given on 9/21 during the drive through flu clinic. Specialty nurse in flu clinic documented in nursing note. Patient was informed. Other Relevant HX: Other: duplicate vaccine
Age: 54.0
Sex: M
Vaccine: VARZOS
Symptoms: Pruritus
Clinical narrative: Reported Symptoms: 10037087: PRURITUS; Narrative: Pt received 1st Zoster vaccine on 11/14/2023 and 2nd series on 1/19/2024. Provider documented on 5/14/24 that Pt had pruritus with vaccine administration. 5/14/24 PCP visit: Pt reported he had itching for some time after receiving the "shingles" vaccine. Pt currently denies any symptoms. Other Relevant HX: n/a Other:
Age: 81.0
Sex: M
Vaccine: FLUX
Symptoms: Syringe issue
Clinical narrative: Reported Symptoms: 10069327: PRODUCT QUALITY ISSUE; 10069892: SYRINGE LEAK; Narrative: Flu vaccine leaked from vial/syringe. Other Relevant HX: Other: vaccine leaked
Age: 81.0
Sex: M
Vaccine: FLUX
Symptoms: Needle issue
Clinical narrative: Reported Symptoms: 10069327: PRODUCT QUALITY ISSUE; Narrative: Patient wanted flu shot and hub was broke. Liquid flowing out of hub. Patient was not receiving vaccine and had to be poked twice. Patient was agreeable. No redness, swelling or bleeding at site. New flu shot was pulled and given. Patient aware of defect and agreeable. Other Relevant HX: Other: hub broke
Age: 65.0
Sex: M
Vaccine: TTOX
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Reported Symptoms: 10037087: PRURITUS; 10037844: RASH; 10046735: URTICARIA; Narrative: Other Relevant HX: Other: URTICARIA; RASH
Age: 1.5
Sex: F
Vaccine: DTAP, HIBV, MMRV, PNC20
Symptoms: Pyrexia, Rash
Clinical narrative: Fever + rash started 12 days after vaccination
Age: 54.0
Sex: M
Vaccine: FLU3
Symptoms: Arthralgia, Fatigue, Gait disturbance, Listless, Myalgia
Clinical narrative: The patient reports feeling a lot of muscle and joint pain. He also reports feeling excessively tired, tiredness when walking that does not improve, listlessness and a lot of pain that despite having passed months continue to see no improvement in the pain in her legs, difficulty walking due to fatigue and muscle and joint pain.
Age: 54.0
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: The patient reports feeling a lot of muscle and joint pain. He also reports feeling excessively tired, tiredness when walking that does not improve, listlessness and a lot of pain that despite having passed months continue to see no improvement in the pain in her legs, difficulty walking due to fatigue and muscle and joint pain.
Age: 17.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Computerised tomogram normal, Fatigue, Headache, Laboratory test normal, Magnetic resonance imaging normal
Clinical narrative: usual headache/fatigue and symptoms post vaccine, but has had on and off headaches ongoing since vaccination. issues with orthostasis, incapacitating headaches.
Age: 17.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Orthostatic hypotension
Clinical narrative: usual headache/fatigue and symptoms post vaccine, but has had on and off headaches ongoing since vaccination. issues with orthostasis, incapacitating headaches.
Age: 17.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Blood immunoglobulin A, Blood immunoglobulin G, Blood pressure abnormal, Computerised tomogram normal, Cyanosis
Clinical narrative: usual headache/fatigue and symptoms post vaccine, but has had on and off headaches ongoing since vaccination. issues with orthostasis, incapacitating headaches.
Age: 17.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Fatigue, General physical condition abnormal, Headache, Hypoaesthesia, Influenza like illness
Clinical narrative: usual headache/fatigue and symptoms post vaccine, but has had on and off headaches ongoing since vaccination. issues with orthostasis, incapacitating headaches.
Age: 17.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Influenza virus test negative, Lumbar puncture normal, Magnetic resonance imaging normal, Malaise, Muscular weakness
Clinical narrative: usual headache/fatigue and symptoms post vaccine, but has had on and off headaches ongoing since vaccination. issues with orthostasis, incapacitating headaches.
Age: 17.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Musculoskeletal stiffness, Myalgia, Pyrexia, SARS-CoV-2 test negative, Streptococcus test negative
Clinical narrative: usual headache/fatigue and symptoms post vaccine, but has had on and off headaches ongoing since vaccination. issues with orthostasis, incapacitating headaches.
Age: 17.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Vomiting
Clinical narrative: usual headache/fatigue and symptoms post vaccine, but has had on and off headaches ongoing since vaccination. issues with orthostasis, incapacitating headaches.
Age: 82.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Arthralgia, Discomfort, Pain in extremity
Clinical narrative: Patient called pharmacy on 12/8/2024 to report she was still having issues with a sore shoulder/arm from flu shot received on 10/14/2024. She stated she has been taking otc acetaminophen on occasion which helps alleviate the pain/discomfort.  I suggested to follow up w/PCP.
Age: 33.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain
Clinical narrative: Site: Pain at Injection Site-Medium, Additional Details: Patient experiencing ongoing pain in injection site arm. Referred for evaluation to PCP.
Age: 79.0
Sex: F
Vaccine: RSV
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Mild, Additional Details: Symptoms were all located near the site of administration including redness, itching, tenderness and swelling, which started about 1 week after administration and subsided about 4 or 5 days later, but some are still present after 7 days
Age: 48.0
Sex: F
Vaccine: FLUC4
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Other Vaccines:  VaccineTypeBrand: FLUCIVAX TRIVALEN 24-25; Manufacturer: SEQIRUS; LotNumber: 391416; Route: IM; BodySite: LEFT ARM; Dose: 1; VaxDate: 11/07/2024
Age: 54.0
Sex: F
Vaccine: PNC20
Symptoms: Anaphylactic reaction, Cheilitis, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Swollen lymph nodes on neck on right side-Medium, Additional Details: Patient reported 11/14/24 with chief complaint of redness, swelling, itching at injection site in right arm (only Prevnar 20 vaccine administered at this site) and rash on right side of neck, rash/blisters on right side of lip, swollen lymph nodes on neck on right side, and itchy throat.  Patient had vaccine on 11/9/24 and reaction did not develop until 11/14/24. Advised patient to take Benadryl immediately and follow with healthcare provider the next business day if needed more emergently.  , Other Vaccines:  VaccineTypeBrand: Pfizer 2024-2025 COVID 19 12 yr +; Manufacturer: Pfizer; LotNumber: LN0588; Route: IM; BodySite: Left Arm; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: Flucelevax Trivalent 2024-2025; Manufacturer: Seqirus; LotNumber: 946621; Route: IM; BodySite: Left Arm; Dose: ; VaxDate: UNKNOWN
Age: 54.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site swelling, Lymphadenopathy, Pruritus, Rash, Rash vesicular
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Swollen lymph nodes on neck on right side-Medium, Additional Details: Patient reported 11/14/24 with chief complaint of redness, swelling, itching at injection site in right arm (only Prevnar 20 vaccine administered at this site) and rash on right side of neck, rash/blisters on right side of lip, swollen lymph nodes on neck on right side, and itchy throat.  Patient had vaccine on 11/9/24 and reaction did not develop until 11/14/24. Advised patient to take Benadryl immediately and follow with healthcare provider the next business day if needed more emergently.  , Other Vaccines:  VaccineTypeBrand: Pfizer 2024-2025 COVID 19 12 yr +; Manufacturer: Pfizer; LotNumber: LN0588; Route: IM; BodySite: Left Arm; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: Flucelevax Trivalent 2024-2025; Manufacturer: Seqirus; LotNumber: 946621; Route: IM; BodySite: Left Arm; Dose: ; VaxDate: UNKNOWN
Age: 54.0
Sex: F
Vaccine: PNC20
Symptoms: Throat irritation
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Swollen lymph nodes on neck on right side-Medium, Additional Details: Patient reported 11/14/24 with chief complaint of redness, swelling, itching at injection site in right arm (only Prevnar 20 vaccine administered at this site) and rash on right side of neck, rash/blisters on right side of lip, swollen lymph nodes on neck on right side, and itchy throat.  Patient had vaccine on 11/9/24 and reaction did not develop until 11/14/24. Advised patient to take Benadryl immediately and follow with healthcare provider the next business day if needed more emergently.  , Other Vaccines:  VaccineTypeBrand: Pfizer 2024-2025 COVID 19 12 yr +; Manufacturer: Pfizer; LotNumber: LN0588; Route: IM; BodySite: Left Arm; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: Flucelevax Trivalent 2024-2025; Manufacturer: Seqirus; LotNumber: 946621; Route: IM; BodySite: Left Arm; Dose: ; VaxDate: UNKNOWN
Age: 62.0
Sex: M
Vaccine: FLU4
Symptoms: Dysphagia, Hypoaesthesia oral, Throat tightness
Clinical narrative: Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Additional Details: Pt has taken flu shots in the past with no issues. However she had a similiar, stronger reaction with covid shot a few years ago. I administered  shot and  a few minutes later  pt was saying she could not swallow and went to get water and was swallowing and remaining calm.  SHe sat down and was fine. I gave her 1 tablet of Benadryl. I called pt a few days later and she said she also had numbness around her mouth .  She was fine Sunday am. All symptoms disapeared., Other Vaccines:  VaccineTypeBrand: fluzone trivalent 24-25; Manufacturer: sanofi; LotNumber: ut8485la; Route: im; BodySite: left arm; Dose: ; VaxDate: UNKNOWN
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema, Rash
Clinical narrative: Site: Redness at Injection Site-Medium, Systemic: Allergic: Rash Generalized-Medium
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Confusional state, Dizziness, Dyskinesia, Syncope
Clinical narrative: Systemic: Chills-Severe, Systemic: Confusion-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: had spasmodic movements-Severe, Systemic: Shakiness-Severe, Additional Details: After administering vaccines to patient and her walking over to waiting area, patient got dizzy.  She sat down.  She complained of being dizzy to a woman next to her who happened to be a nurse.  She started to have involuntary movements.  911 was called.  The nurse told her to breath.  The episode was brief.  She was brought juice and she slowly started to feel better and less dizzy as EMS came.  She went to hospital. Will follow up tomorrow with patient., Other Vaccines:  VaccineTypeBrand: flucelvax syringe; Manufacturer: seqirus; LotNumber: 391417; Route: intramuscular; BodySite: left deltoid; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: boostrix tdap syringe; Manufacturer: glaxosmithkline; LotNumber: 235D2; Route: intramuscular; BodySite: left deltoid; Dose: ; VaxDate: UNKNOWN
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Unresponsive to stimuli
Clinical narrative: Systemic: Chills-Severe, Systemic: Confusion-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: had spasmodic movements-Severe, Systemic: Shakiness-Severe, Additional Details: After administering vaccines to patient and her walking over to waiting area, patient got dizzy.  She sat down.  She complained of being dizzy to a woman next to her who happened to be a nurse.  She started to have involuntary movements.  911 was called.  The nurse told her to breath.  The episode was brief.  She was brought juice and she slowly started to feel better and less dizzy as EMS came.  She went to hospital. Will follow up tomorrow with patient., Other Vaccines:  VaccineTypeBrand: flucelvax syringe; Manufacturer: seqirus; LotNumber: 391417; Route: intramuscular; BodySite: left deltoid; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: boostrix tdap syringe; Manufacturer: glaxosmithkline; LotNumber: 235D2; Route: intramuscular; BodySite: left deltoid; Dose: ; VaxDate: UNKNOWN
Age: 51.0
Sex: F
Vaccine: FLU4
Symptoms: Dysphagia, Throat tightness
Clinical narrative: Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild
Age: 74.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Pyrexia
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Fever-Mild, Additional Details: Unclear if just a regular injection site reaction or cellulitis. Immunizer stated she gave vaccine in LEFT arm. Pt presenting with symptoms in RIGHT arm. Pt stated Rph gave it in the right arm, Rph not here today, unclear if we documented incorrectly which arm. Advised pt to be seen at urgent care to check for cellulitis.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Systemic: Dizziness / Lightheadness-Severe, Additional Details: Patient stated when she gets Moderna Covid she feels very lightheaded as if she is going to faint.
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild
Age: 28.0
Sex: M
Vaccine: FLUC4
Symptoms: Dizziness, Nausea
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Nausea-Mild
Age: 27.0
Sex: M
Vaccine: FLUC4
Symptoms: Chills, Confusional state, Dizziness, Flushing, Hyperhidrosis
Clinical narrative: Systemic: Chills-Mild, Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Seizure-Mild, Additional Details: n/a, Other Vaccines:  VaccineTypeBrand: Covid(Moderna); Manufacturer: Moderna; LotNumber: 3043333; Route: intramuscular; BodySite: left arm; Dose: 1; VaxDate: 11/15/2024
Age: 27.0
Sex: M
Vaccine: FLUC4
Symptoms: Seizure, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Chills-Mild, Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Seizure-Mild, Additional Details: n/a, Other Vaccines:  VaccineTypeBrand: Covid(Moderna); Manufacturer: Moderna; LotNumber: 3043333; Route: intramuscular; BodySite: left arm; Dose: 1; VaxDate: 11/15/2024
Age: 50.0
Sex: F
Vaccine: FLU4
Symptoms: Chest discomfort, Chest pain
Clinical narrative: Systemic: Chest Tightness / Heaviness / Pain-Mild, Other Vaccines:  VaccineTypeBrand: HEPLISAV-B; Manufacturer: DYNAVAX; LotNumber: 945655; Route: INTRAMUSCULAR; BodySite: LEFT ARM; Dose: 2; VaxDate: 10/22/2024, VaccineTypeBrand: COVID-19; Manufacturer: MODERNA; LotNumber: 8079568; Route: INTRAMUSCULAR; BodySite: LEFT ARM; Dose: 1; VaxDate: 10/22/2024, VaccineTypeBrand: SHINGRIX; Manufacturer: GSK; LotNumber: 52F7M; Route: INTRAMUSCULAR; BodySite: LEFT ARM; Dose: 2; VaxDate: 10/22/2024
Age: 54.0
Sex: M
Vaccine: FLU4
Symptoms: Asthenia, Dizziness, Hypotension
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Hypotension-Mild, Systemic: Weakness-Medium, Additional Details: BP 128/62; OSat: 100%; HR 61; Gave him water and chips and observed him for 10-15 minutes after which he was fine.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling, Injection site warmth, Pain
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Severe, Additional Details: a long swollen area running down the arm about 6-8 inches long that started within a week from receiving injection and gradually got bigger. warm to touch, slightly achy. patient can still work out
Age: 52.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site haemorrhage
Clinical narrative: Site: Redness at Injection Site-Mild, Additional Details: Pt complained that he was bleeding from the injection site for both vaccines. Pharmacist advised pt that this is a normal occurance when a vaccine is given.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Injection site pruritus, Nausea, Unresponsive to stimuli
Clinical narrative: Site: Itching at Injection Site-Mild, Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Nausea-Mild, Additional Details: Patient did not have any injection site reactions. System required me to select one option in order to submit. Was unresponsive for 3 min, never lost consciousness. Remained coherent including when EMS arrived.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Systemic: Headache-Medium, Additional Details: pt came in on 11/16/2024 stating that she had been experiencing headaches since she received her covid shot on 10/26. It was recommended she make an appointment with her regular doctor.
Age: 82.0
Sex: M
Vaccine: RSV
Symptoms: Dyspnoea, Immediate post-injection reaction
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Severe, Additional Details: patient complain of difficutly breathing immediately after receiving vacinations. rph administered an epipen which the patient responded to within a couple minutes. emt arrived a5-10 minutes later and check the patient out. the patient felt fine and the emt gave them the okay to leave. on followup 6 hours later patient states they are still doing fine without issue. , Other Vaccines:  VaccineTypeBrand: covid; Manufacturer: pfizer; LotNumber: lp1780; Route: im; BodySite: left arm; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: flu; Manufacturer: sanofi; LotNumber: ub8532ba; Route: im; BodySite: left arm; Dose: ; VaxDate: UNKNOWN
Age: 35.0
Sex: M
Vaccine: MMR
Symptoms: Dizziness
Clinical narrative: Systemic: Dizziness / Lightheadness-Severe, Additional Details: PT needed to be place sitting on the floor, was cared for, offered water. Was ok to move around after 15 minutes. Pt left on there own accompanied by spouse and children, No issues, Other Vaccines:  VaccineTypeBrand: varivaX; Manufacturer: MSD; LotNumber: Y007176; Route: SC; BodySite: LEFT ARM; Dose: ; VaxDate: UNKNOWN
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: Site: Pain at Injection Site-Severe
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Loss of consciousness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient felt dizzy during time sitting after injections. on way out with parents she passed out. EMS was called and they stayed with her for about 15 minutes. I was working so I do not know more of the details., Other Vaccines:  VaccineTypeBrand: flucelvax; Manufacturer: sequiris; LotNumber: 391416; Route: intramuscular; BodySite: left arm; Dose: ; VaxDate: UNKNOWN
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Loss of consciousness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: during the 15 min after injection, felt dizzy, light headed. Once family took girls out  to car, on way out of the store, she passed out in front store. EMS was called and stayed with them for about 15 min. I was working and have not heard update. , Other Vaccines:  VaccineTypeBrand: flucelvax; Manufacturer: seqirus; LotNumber: 391416; Route: intramuscular; BodySite: right arm; Dose: ; VaxDate: UNKNOWN
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Dizziness, Dyskinesia, Eye swelling
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fever-Medium, Systemic: muscle jerking, nausea-Medium, Systemic: Headache-Medium, Systemic: Nausea-Medium, Systemic: Shakiness-Medium, Systemic: Weakness-Medium, Additional Details: patient recieved vaccine on friday and reported on sunday that she felt she was having a bad reaction to vaccine, we counseled her to seek medical attention- said she just felt really bad and had some face swelling saturday, but swelling went down since and that she has had flu- like symptoms as well as muscle jerking, weakness
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Feeling abnormal, Headache, Influenza like illness, Injection site erythema, Injection site pain
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fever-Medium, Systemic: muscle jerking, nausea-Medium, Systemic: Headache-Medium, Systemic: Nausea-Medium, Systemic: Shakiness-Medium, Systemic: Weakness-Medium, Additional Details: patient recieved vaccine on friday and reported on sunday that she felt she was having a bad reaction to vaccine, we counseled her to seek medical attention- said she just felt really bad and had some face swelling saturday, but swelling went down since and that she has had flu- like symptoms as well as muscle jerking, weakness
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Mouth swelling, Nausea, Pyrexia, Swelling face, Swollen tongue
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fever-Medium, Systemic: muscle jerking, nausea-Medium, Systemic: Headache-Medium, Systemic: Nausea-Medium, Systemic: Shakiness-Medium, Systemic: Weakness-Medium, Additional Details: patient recieved vaccine on friday and reported on sunday that she felt she was having a bad reaction to vaccine, we counseled her to seek medical attention- said she just felt really bad and had some face swelling saturday, but swelling went down since and that she has had flu- like symptoms as well as muscle jerking, weakness